Pediatric Rheumatology Flashcards

1
Q

What are the hallmarks of inflammation?

A

calor - heat

rubor - redness

tumor - swelling

dolor - pain

functio laesia - loss of function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

immunological bases of autoinflammatory disease vs. autoimmune disease

A

autoinflammatory - perturbation of innate immunity

autoimmune disease - perturbation of adaptive immunity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

cellular basis of autoinflammatory disease vs. autoimmune disease

A

inflammatory - neutrophils, macrophages

autoimmune - B cells, T cells, T regulatory cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

clinical recognition of autoinflammatory disease vs. autoimmune disease

A

inflammatory - family history, specific symptoms

autoimmune - MHC associations and autoantibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

conceptual understanding of autoinflammatory disease vs. autoimmune disease

A

inflammatory - tissue-specific danger signals

autoimmune - breaking of self-tolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

therapy of autoinflammatory disease vs. autoimmune disease

A

inflammatory - block cytokine cascades

autoimmune disease - block lymphocytes or their products

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the epidemiology of juvenile idiopathic arthritis (sJIA)?

A

5-15% of children with JIA

male:female ratio is about equal

age at onset is any time in childhood

can occur in adults

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How is arthritis classified in children?

A

joint swelling or effusion

OR

2 or more of the following:

  • limited range of motion
  • pain on range on motion
  • warmth
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

juvenile idiopathic arthritis

A

arthritis for 6 weeks

diagnosis of exclusion

onset type defined by type of disease in first 6 months

onset age 16 or younger

prevalence of chronic childhood arthritis is 20-100:100k

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

systemic JIA

A

arthritis, usually polyarticular:

  • large and small joints, usually symmetric

spiking quotidian (once or twice daily) fever

evanescent rash:

  • salmon colored patches or macules
  • trunk, proximal extremities, axilla, groin
  • appears with fever

hepatosplenomegaly, symmetric and generalized lymphadenopathy, serositis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the epidemiology of sJIA?

A

5-15% of children with JIA

any age including adults: stills

male = female

mild to severe

most morbidity and mortality of all JIA subtypes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the pathophysiology of sJIA?

A

IL-1, IL-6, and TNFalpha driven inflammation via abnormal cytokine expression - autoinflammatory

no consistent HLA associations

SNP in IL-6 regulatory region

polymorphism in macrophage inhibitory factor gene -> worse outcome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the clinical signs of sJIA?

A

symptoms may not all present simultaneously - increases in severity over time

fever can be isolated initially - high spiking to 39 C or above, 1-2x daily with rapid return to normal or below

10% have no arthritis at presentation

wide range of presentation from mild to critically ill

rash, serositis, generalized lymphadenopathy, hepatosplenomegaly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the important features of labwork in sJIA?

A

complete blood count signs of inflammation - anemia, leukocytosis, thrombocytosis

elevated ESR, CRP, ferritin, d-dimers

elevated LFTs especially LDH

signs of DIC - prolonged coags, high d-dimers, low fibrinogen

rare to be ANA+

RF+ is exclusion criteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is macrophage activation syndrome?

A

complication of sJIA

severe hyperinflammatory state - can be fatal

5-8% of sJIA patients

labs:

  • DIC -> low ESR, low fibrinogen
  • pancytopenia
  • elevated triglycerides, LFTs
  • very high ferritin
  • high D-dimers
  • hemophagocytosis
  • polyclonal elevation of immunoglobulins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the treatment for sJIA?

A

nonsteroidal anti-inflammatories

glucocorticoids

methotrexate

biologics - anti IL-1, anti IL-6 > anti-TNF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the prognosis of sJIA?

A

variable - monophasic, recurrent, persistent

about half of patients develop chronic, destructive polyarthritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the clinical presentation of Kawasaki Disease?

A

fever for more than 5 days

plus at least four of the following:

  • changes in peripheral extremities (edema/erythema) or perineum - edema or erythema of hands or feet, periungual desquamation
  • polymorphous rash: erythematous macular, papular, annular, morbilliform, no vesicles
  • bilateral non-exudative conjunctivitis
  • changes of lips and oral cavity - injected and/or fissured lips, strawberry tongue, injected pharynx
  • cervical lymphadenopathy with at leas one node >1.5cm, usually unilateral
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the epidemiology of KD?

A

highest incidence in Japan

in US - asian 39/100k > african american > hispanic > white (11/100k)

85% under age of 5, peak 2-3 years old

slight male predominance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the pathogenesis of KD?

A

likely an infectious trigger

superantigen stimulating large numbers of T cells

genetic predisposition

systemic necrotizing vasculitis with predilection for coronary arteries (small and medium size vessels

inflammatory infiltrate into vessels -> disruption of lamina elastica -> aneurisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the disease course for Kawasaki Diseaes?

A

acute febrile phase: 10-14 days

subacute phase: 2-4 weeks

convalescent phase: months

22
Q

acute febrile phase of KD

A

10-14 days

preceding URI or GI symptoms

fever and cutaneous symptoms

carditis, pericarditis, abdominal pain

23
Q

subacute phase of KD

A

2-4 weeks

desquamation, arthritis, aneurisms

24
Q

convalescent phase of KD

A

lasts for months

asymptomatic

25
What are the laboratory findings of KD?
increased ESR and CRP elevated white blood cell count anemia platelets rise by 2nd week ECG and echocardiogram - carditis, coronary aneurisms
26
KD therapy
goal - control acute inflammation and symptoms prevent long-term sequelae and aneurismss high dose **aspirin and IVIG** within the first 10 days greatly reduces risk of coronary involvement steroids, biologics if **refractory** to IVIG
27
What is the prognosis of KD?
IVIG reduces incidence of aneurisms by 78% 5% of kids treated with IVIG develop aneurisms almost always monophasic - very rare to recur risk of cardiac death due to aneurisms
28
What are the organs affected by Henoch-Schonlein Purpura?
purpuric rash in the skin vasculitis of the kidney - proteinuria abdominal pain with bloody diarrhea arthritis
29
What is the epidemiology of HSP?
most common childhood vasculitis most frequent between 3-15 years mean age of onset is approximately 7 years old female-male ratio is 1:1.5 more cases in winter months
30
What is the pathogenesis of HSP
could be triggered by Group A strep 30-50% preceded by URI IgA-mediated dysregulated immune response to antigen alternative complement pathway is triggered familial clustering - HLA predisposition
31
What are the clinical signs of HSP?
palpable purpura - dependent distribution that can be preceded by macules and urticaria GI manifestations within a week of rash due to vasculitis **currant jelly stools** colicky abdominal pain - risk of **_intussusception_** **kidney involvement** within 4-6 weeks of rash - microscopic hematuria, proteinuria, and renal failure **arthralgia, arthritis** in 50-80% predominantly lower extremities **subcutaneous edema** often periarticular scrotal pain and swelling
32
What are laboratory findings in HSP?
**NO thrombocytopenia!** basic labs often unremarkable elevated IgA with deposition in mesangial and GI vasculature check urinalysis (not dip) with spot protein/creatinine and blood pressure
33
What is the treatemtn for HSP?
symptomatic - hydration, bland diet, analgesia, anti-inflammatories if severe abdominal pain, bloody stools, evaluate for intussusception and consider steroids corticosteroids do not prevent renal disease but may be helpful when renal involvement is established
34
What is the prognosis of HSP?
in 2/3 of cases, HSP runs entire course within 4 weeks (monophasic) generally prognosis is excellent \<5% progress to renal failure late kidney involvement rare but possible - monitor urinalysis
35
What is juvenile dermatomyositis?
inflammatory myopathy systemic vasculopathy cutaneous findings proximal symmetric myositis progressive proximal muscle weakness not associated with cancer in children
36
What is the epidemiology of dermatomyositis?
incidence of 3.2/million children/year 73% of cases in the US are caucasian female:male ratio is 2.3:1 average age at onset is 6.7 years but 25% are below 4
37
What are the diagnostic criteria of juvenile dermatomyositis?
definite diagnosis reqires rash plus 3 or 4 of the following: symmetrical proximal muscle weakness elevation of skeletal muscle enzymes in serum electromyographic findings typical of myositis muscle biopsy findings typical of JDM
38
What is the etiology of juvenile dermatomyositis?
**UV exposure** antibodies - myositis specific and associated genetic susceptibility - 80% have DQQA1\*0501 cytokine polymorphisms: TNF-alpha
39
What is the pathogenesis of juvenile dermatomyositis?
putative antigen and/or immune complexes activate endothelial cells endothelium is damaged by complement activation - release of von Willebrand factor antigen occlusion of capillaries and arterioles results in infarction of local tissues cutaneous manifestations caused by capillary and arteriolar vasculopathy and occlusion dermis - vascular inflammation and edema thinned epidermis
40
What are the systemic clinical signs of dermatomyositis?
disease onset is usually insidious nonspecific symptoms - fatigue, low grade fever, weight loss, irritability, arthralgia, and abdominal pain can be acute with high fever and profound clinical symptoms
41
What are the clinical signs of juvenile dermatomyositis in the skin?
rash + weakness in 50% of cases rash occurs first in 25% of cases **rash is prominent on sun-exposed surfaces** - torso (shawl or V distribution) - extensor surfaces of extremities - scalp with hair loss due to chronic inflammation
42
Gottron's papules
a finding of juvenile dermatomyositis hypertrophic, reddish pink areas of skin with are papular and scaly occur over the MCP and interphalangeal joints as well as elbows and knees heal as atrophic colorless bands
43
heliotrope rash
a finding in juvenile dermatomyositis periorbital violaceous erythema may cross nasal bridge
44
What does diffuse vasculopathy signify in juvenile dermatomyositis?
nail bed telangiectasia infarction of oral epithelium and skin-folds digital, skin and gastrointestinal ulceration
45
What are the clinical signs in juvenile dermatomyositis pertaining to muscle?
proximal muscle weakness often insidiuous cmon signs include difficulty climbing stairs, getting on school bus, combing hair, arising from bed or chair **Gower's sign** - difficulty rising from floor inability to raise head off bed (neck flexors) inability to perform a sit-up (abdominals)
46
What are other clinical signs of juvenile dermatomyositis?
hoarse voice, nasal speech dysphagia - poor prognostic sign requiring aggressive mdial management shortness of breath - interstitial lung diseae constipation, hematochezia from weakness, gut vasculopathy
47
What are the late clinical signs of juvenile dermatomyositis?
muscle and fat atrophy calcinosis cutis - in subcutaneous tissue and fascia - 20% of patients - consequenece of delayed/insufficient suppression of inlammation - potential source of ulceration, infection
48
What are the common laboratory findings in juvenile dermatomyositis?
elevated muscle enzymes reflecting leaky muscle membranes - can be subtle **- CK** **- aldolase** **- AST, ALT** **- lactate dehydrogenase** **elevated von Willebrand factor** antigen reflecting disrupted endothelium **CRP/ESR usually normal** anemia is possible **RF is negative** kidney function tests are normal myositis specific antibodies predict findings, prognosis
49
What are the complications of juvenile dermatomyositis?
decreased bone density - increased fractures with increase disease duration calcifications - associatated with TNF-alpha-308A, untreated long disease, major contributor to mortality and morbidity partial lipodystrophy - associated with insulin resistant diabetes
50
What is the treatment for juvenile dermatomyositis?
oral and IV corticosteroids methotrexate other steroids sparing immunosuppressants - cyclosporine, mycophenolate mofetil IVIG for skin disease hydroxycloroquine for skin disease calcium and vitamin D sunscreen at least SPF 45
51
What is the prognosis of juvenile dermatomyositis?
current morality is 1% long term outcome secondary to systemic vasculopathy is unclear - cardiovascular morbidity likely long duration of untreated disease predicts poor outcome aggressive treatment strategies decreases time to remission